Filing Details

Accession Number:
0001104659-23-005546
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-23 06:08:18
Reporting Period:
2023-01-20
Accepted Time:
2023-01-23 06:08:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
894158 Theriva Biologics Inc. TOVX Pharmaceutical Preparations (2834) 133808303
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263501 A Steven Shallcross C/O Theriva Biologics, Inc.,
9605, Medical Center Drive, Suite 270
Rockville MD 20850
Ceo And Cfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-20 25,000 $0.75 135,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct